FDA Establishes Public Docket for Cellular, Tissue, and Gene Therapies Advisory Committee Meeting

Summary

The FDA is requesting public comments on its upcoming meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee, which will discuss regulatory expectations for xenotransplantation products, including human cells and animal organs for transplantation into humans.